Form 4: Cyrus Capital Disposes 1.305M Garrett Motion (GTX) Shares at ~$13.00
Rhea-AI Filing Summary
Cyrus Capital Partners and related reporting persons disclosed sales of Garrett Motion Inc. (GTX) common stock on August 19-20, 2025. The filing reports disposition of 1,300,000 shares on 08/19/2025 at a weighted-average price of $13.00–$13.05 and 5,000 shares on 08/20/2025 at a weighted-average price of $13.25–$13.255. After these transactions the reporting persons beneficially owned 21,123,348 shares, held indirectly through investment funds and related entities. The filing identifies the reporting persons as Cyrus Capital Partners, L.P., Cyrus Capital Partners GP, L.L.C., and Stephen C. Freidheim, who is a director and the Chief Investment Officer of Cyrus Capital Partners. Footnotes clarify the holdings are through multiple Cyrus funds and that each reporting person disclaims beneficial ownership except to the extent of pecuniary interest.
Positive
- Transparent disclosure of weighted-average sale prices and offer to provide per-trade breakouts on request
- Continued substantial beneficial ownership post-sale (21,123,348 shares), indicating the reporting persons retain a large stake
Negative
- Insider selling of 1,305,000 GTX shares on 08/19–08/20/2025, which may be viewed negatively by some investors
- Sales by a 10% owner and director can raise governance or signaling concerns despite disclaimers
Insights
TL;DR: Large insider sales disclosed; beneficial ownership remains sizable, signaling liquidity-taking rather than full exit.
The Form 4 shows aggregate sales of 1,305,000 GTX shares across two dates at weighted-average prices in a narrow range around $13.00–$13.255. The sellers are an investment manager (Cyrus Capital Partners), its GP, and the CIO; ownership post-sale remains 21.1 million shares held indirectly by Cyrus-managed funds. For investors, this is a clear, transparent disclosure of realized selling by a significant holder but not a divestment of the entire position. The filing includes customary disclaimers limiting beneficial ownership except for pecuniary interest. Impact is informational and routine for large institutional managers managing fund liquidity.
TL;DR: Reporting complies with Section 16 disclosure; structure and footnotes detail indirect ownership and disclaimers.
The submission is properly signed by the GP and individual reporting person and contains footnotes explaining the indirect ownership structure through multiple Cyrus funds and the sole-member GP relationship. The weighted-average pricing disclosures and willingness to provide breakouts upon request align with Form 4 practices. From a governance perspective, filing formality and clarifying notes reduce ambiguity about who controls the securities, which supports regulatory transparency even as significant shares were sold.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 5,000 | $13.2515 | $66K |
| Sale | Common Stock | 1,300,000 | $13.0014 | $16.90M |
Footnotes (1)
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.05, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. These securities of the Company are beneficially owned by (i) Cyrus Capital Partners, L.P. ("Cyrus Capital Partners"), as a result of being the investment manager of certain private investment funds that directly hold the securities, including Cyrus 1740 Master Fund, L.P., Canary SC Master Fund, L.P., Cyrus Opportunities Master Fund II, Ltd., Crescent 1, L.P., CRS Master Fund, L.P., Cyrus Select Opportunities Master Fund, Ltd., Cyrus Select Opportunities Master Fund II, L.P., Peterson Capital Investors LLC, and PJ A Capital LLC (the "Cyrus Funds"), (ii) Cyrus Capital Partners GP, L.L.C. ("Cyrus Capital GP"), as a result of being the sole general partner of Cyrus Capital Partners, and (iii) Stephen C. Freidheim, as a result of being the Chief Investment Officer of Cyrus Capital Partners and the sole member and manager of Cyrus Capital GP (collectively, the "Reporting Persons"). (Continued from footnote 2) Each of the Reporting Persons disclaims beneficial ownership of any securities reported by any person except to the extent of his or its pecuniary interest therein, if any. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.25 to $13.255, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.